Stocks
KBC Group NV Boosts Stake in Amgen Inc., Buys Additional Shares
KBC Group NV has increased its stake in Amgen Inc., buying an additional 130,497 shares during the second quarter. This represents a 51.7% increase in the company's holdings in Amgen.
The fund now owns approximately 382,676 shares of Amgen's stock, valued at $138,574,000 as of the end of the most recent reporting period. Institutional investors own around 76.50% of Amgen's stock.
Amgen reported earnings per share (EPS) of $6.29 for the quarter, beating analysts' estimates by $0.67. The company has set its FY 2026 guidance at 22.300-23.500 EPS.